Evidence map›Paper›PMID 36412825›Full record

ArticlePharmacy (Basel, Switzerland)2022

Study Destination Choice and Career Preferences of International Students at China Pharmaceutical University.

Raphael N Alolga, Said Abasse Kassim, Pierre Dramou

Abstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Raphael N AlolgaState Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, Department of Pharmcognosy, China Pharmaceutical University, Nanjing 210009, China.
Said Abasse KassimDépartement de management, Faculté des sciences de l'administration, Université Laval, 2325 Rue de l'Université, Québec, QC G1V 0A6, Canada.ORCID 0000-0003-2136-0825
Pierre DramouDepartment of Analytical Chemistry, School of Science, China Pharmaceutical University, Nanjing 210009, China.ORCID 0000-0002-5606-034X

Funding

Canadian Institutes of Health Research (CIHR) grant no. IF5 184125China Pharmaceutical University 3150020061; 3150050051
6 · The paper itself

Abstract

This study had two main thematic aims: first, to determine the factors that influenced the choice of international students at China Pharmaceutical University (CPU) to consider China as a study destination; second, to determine the career preferences of international students upon completion of their various programs of study. As a cross-sectional study, relevant data were collected from undergraduate pharmacy students and postgraduates using a self-administered questionnaire. On the whole, the five most important pull factors that influenced the choice of China as the study destination for the respondents were: (1) quality of education, (2) quality of academic staff, (3) security, (4) desire to obtain a certificate from a foreign country and (5) availability of scholarship opportunities. With respect to the career choices, the top three career preferences of the international students were: (1) to work in the pharmaceutical industry (i.e., pharmaceutical manufacturing companies), (2) to practice clinical pharmacy and (3) to seek employment opportunities outside their countries. This study provides additional details on why China has gradually become a study destination of choice for international students. The career preferences of students could be useful in the design of academic programs that could meet their job aspirations.

Indexed as

career preferenceChinainternational studentspharmacypull factorsstudy destination

Identifiers

PMID36412825
PMCPMC9680234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.